Janssen M - Search Results

1

Pathogen reduction of blood components during outbreaks of infectious diseases in the European Union: an expert opinion from the European Centre for Disease Prevention and Control consultation meeting.

Domanović D, Ushiro-Lumb I, Compernolle V, Brusin S, Funk M, Gallian P, Georgsen J, Janssen M, Jimenez-Marco T, Knutson F, Liumbruno GM, Mali P, Marano G, Maryuningsih Y, Niederhauser C, Politis C, Pupella S, Rautmann G, Saadat K, Sandid I, Sousa AP, Vaglio S, Velati C, Verdun N, Vesga M, Rebulla P. Domanović D, et al. Among authors: janssen m. Blood Transfus. 2019 Nov;17(6):433-448. doi: 10.2450/2019.0288-19. Epub 2019 Dec 11. Blood Transfus. 2019. PMID: 31846608 Free PMC article.

2

Modeling the transmission risk of emerging infectious diseases through blood transfusion.

Oei W, Janssen MP, van der Poel CL, van Steenbergen JE, Rehmet S, Kretzschmar ME. Oei W, et al. Transfusion. 2013 Jul;53(7):1421-8. doi: 10.1111/j.1537-2995.2012.03941.x. Epub 2012 Nov 1. Transfusion. 2013. PMID: 23113823

3

Health economics and outcomes methods in risk-based decision-making for blood safety.

Custer B, Janssen MP; Alliance of Blood Operators Risk-Based Decision-Making (RBDM) Initiative. Custer B, et al. Transfusion. 2015 Aug;55(8):2039-47. doi: 10.1111/trf.13080. Epub 2015 Apr 9. Transfusion. 2015. PMID: 25855475 Review.

4

A consensus-based tool for ranking the risk of blood-transmissible infections.

Oei W, Neslo R, Janssen MP. Oei W, et al. Transfusion. 2016 Aug;56(8):2108-14. doi: 10.1111/trf.13656. Epub 2016 May 23. Transfusion. 2016. PMID: 27217225

5

Cost-effectiveness of the screening of blood donations for hepatitis E virus in the Netherlands.

de Vos AS, Janssen MP, Zaaijer HL, Hogema BM. de Vos AS, et al. Among authors: janssen mp. Transfusion. 2017 Feb;57(2):258-266. doi: 10.1111/trf.13978. Epub 2017 Jan 31. Transfusion. 2017. PMID: 28144956

6

A WHO tool for risk-based decision making on blood safety interventions.

Janssen MP, Nuebling CM, Lery FX, Maryuningsih YS, Epstein JS. Janssen MP, et al. Transfusion. 2021 Feb;61(2):503-515. doi: 10.1111/trf.16231. Epub 2020 Dec 25. Transfusion. 2021. PMID: 33368381 Free PMC article.

7

Assessing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease: a European perspective.

Domanović D, Lewin A, O'Leary P, Janner-Jametti T, El Dusouqui SA, Sousa AP, Zaaijer H, Roberts B, Bougard D, Prati D, Nordberg J, Erikstrup C, Janssen M, Lieshout-Krikke R, Gubbe K, O'Flaherty N, Mathy G, Chantillon AM, Lehtisalo R, Sørensen ØH, Tiberghien P, Thomas S. Domanović D, et al. Among authors: janssen m. Blood Transfus. 2024 Sep;22(5):415-419. doi: 10.2450/BloodTransfus.778. Epub 2024 May 16. Blood Transfus. 2024. PMID: 38814884 Free PMC article. Review.

8

Cost-effectiveness of additional blood screening tests in the Netherlands.

Borkent-Raven BA, Janssen MP, van der Poel CL, Bonsel GJ, van Hout BA. Borkent-Raven BA, et al. Transfusion. 2012 Mar;52(3):478-88. doi: 10.1111/j.1537-2995.2011.03319.x. Epub 2011 Aug 31. Transfusion. 2012. PMID: 21880046

9

Viral safety of human plasma-derived medicinal products: impact of regulation requirements.

Velthove KJ, Over J, Abbink K, Janssen MP. Velthove KJ, et al. Transfus Med Rev. 2013 Jul;27(3):179-83. doi: 10.1016/j.tmrv.2013.05.002. Transfus Med Rev. 2013. PMID: 23886505

10

Estimating the transfusion transmission risk of Q fever.

Oei W, Kretzschmar ME, Zaaijer HL, Coutinho R, van der Poel CL, Janssen MP. Oei W, et al. Transfusion. 2014 Jul;54(7):1705-11. doi: 10.1111/trf.12539. Epub 2014 Jan 24. Transfusion. 2014. PMID: 24456030

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,688 results

Search Page

Filters